Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
2/25/2005
 
First Published:
11/1/1992
1.
Phase III Randomized Trial of Strontium-89 vs Palliative Local Radiotherapy in Patients with Hormone-Refractory Prostate Cancer with Painful Osseous Metastases (Summary Last Modified 03/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
any age
EORTC-30921
NCT00002503
Last Modified:
9/21/2007
2.
Phase I/II Study of Strontium-89 in the Treatment of Patients with Endocrine-Resistant Prostate Cancer with Painful Osseous Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Supportive care, Treatment
Completed
any age
NCI
RTOG-8821
RTOG-88-21
Last Modified:
2/1/1999
3.
Phase II Randomized Study of Strontium-89 Alone, Estramustine/Vinblastine, and Strontium-89 plus Estramustine/Vinblastine in Androgen-Independent Prostate Cancer Metastatic to Bone (Summary Last Modified 02/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Other
MSKCC-95094
NCI-V96-0831
Last Modified:
8/1/1999
 
First Published:
12/1/1997
4.
Phase II Study of Sn-117m DTPA versus Strontium-89 in Patients with Painful Bone Metastases Secondary to Prostate Cancer (Summary Last Modified 08/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Closed
18 and over
Pharmaceutical / Industry
DIATIDE-117-30
UCMC-97012201
Last Modified:
4/17/2007
 
First Published:
3/24/2004
5.
Phase II Randomized Study of Doxorubicin and Strontium Chloride Sr 89 With or Without Celecoxib in Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Any age
NCI
MDA-ID-02035
NCT00080782
Last Modified:
11/12/2007
 
First Published:
3/24/2004
6.
Phase II Randomized Study of Hormonal Ablative Therapy, Doxorubicin, and Zoledronate With or Without Strontium Chloride Sr 89 in Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Not specified
NCI
MDA-2003-0922
6459, NCI-6459, NCT00081159
7.
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Other
GUPPS2
NCT00156884
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute